AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0

Triblend VG 2 Tablet ER

Prescription Icon
Prescription Required

Marketer

Akesiss Pharma Pvt Ltd

Salt Composition

Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.2mg)

Overview Triblend VG 2 Tablet ER

Combiflex Duo ER tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by regulating blood glucose. Administer Combiflex Duo ER with meals, consistently at the same time daily for optimal effectiveness. Dosage is determined and adjusted by your physician based on your blood sugar response. Continuous use is crucial, even with controlled blood sugar, as abrupt cessation can lead to elevated glucose, increasing the risk of complications like nephropathy, retinopathy, neuropathy, and limb loss. This medication forms part of a comprehensive diabetes management plan encompassing diet, exercise, and weight management as directed by your doctor. Lifestyle choices are integral to diabetes control. Hypoglycemia (low blood sugar) is a common adverse effect; learn to identify symptoms such as sweating, dizziness, headache, and tremors, and know how to manage them. Regular meals and readily available glucose sources (e.g., sugary snacks, juice) are essential. Alcohol consumption should be minimized due to its potential to exacerbate hypoglycemia. Additional possible side effects include altered taste perception, nausea, diarrhea, abdominal discomfort, cephalalgia, edema, visual disturbances, bone fractures, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before commencing treatment. Consult your physician before use during pregnancy or breastfeeding. Regular blood glucose monitoring, along with periodic blood tests to assess blood cell counts and liver function, are recommended.

Uses of Triblend VG 2 Tablet ER

Managing type 2 diabetes

Major Benefits of Triblend VG 2 Tablet ER:

Follow your doctor's instructions precisely regarding dosage and treatment length for Triblend VG 2 Tablet ER. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Administer this medication on an empty stomach.

Common Side effects of Triblend VG 2 Tablet ER:

  • Nausea
  • Diarrhea
  • Abdominal pain
  • Hypoglycemia (low blood glucose level)
  • Loss of appetite

How to use Triblend VG 2 Tablet ER:

Consume this medication precisely as prescribed by your physician, adhering to both dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Triblend VG 2 Tablet ER on an empty stomach.

How Triblend VG 2 Tablet ER works:

Extended-release Triblend VG 2 tablets contain a triple-drug formulation for diabetes management.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Triblend VG 2 Tablet ER and alcohol is hazardous.

PregnancyPregnancyCONSULT YOUR DOCTOR

The extended-release Triblend VG 2 Tablet might pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against any possible hazards prior to prescription. Patient consultation with their doctor is advised.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Extended-release Triblend VG 2 tablets are likely not safe for breastfeeding mothers. Preliminary human data indicates potential transfer to breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyUNSAFE

Patients with kidney impairment should likely avoid Triblend VG 2 Tablet ER due to potential safety concerns. Medical advice is recommended. Furthermore, its use is discouraged in individuals with severely compromised kidney function.

LiverLiverCAUTION

Exercise caution when prescribing Triblend VG 2 Tablet ER to individuals with hepatic impairment. Dosage modification of Triblend VG 2 Tablet ER may be necessary. Physician consultation is advised. A reduced initial dose of Triblend VG 2 Tablet ER is typically recommended for patients exhibiting mild to moderate liver dysfunction; its use is contraindicated in those with severe liver disease.

What if you forget to take Triblend VG 2 Tablet ER :

Should you forget to take a Triblend VG 2 Tablet ER, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Triblend VG 2 Tablet ER

LabelValue
Addictive None.
Medication Classification Medication for diabetes

FAQs on Triblend VG 2 Tablet ER

Triblend VG 2 Tablet ER contains glimepiride, metformin, and voglibose, three medications working synergistically. This formulation treats type 2 diabetes mellitus by improving blood sugar control in adults, in conjunction with dietary management and physical activity. Glimepiride enhances insulin secretion from the pancreas, reducing blood glucose. Metformin decreases hepatic glucose production and increases insulin sensitivity. Voglibose, an alpha-glucosidase inhibitor, reduces post-meal blood sugar elevations. This medication is unsuitable for managing type 1 diabetes.
Taking Triblend VG 2 Tablet ER may cause common side effects such as low blood sugar, nausea, diarrhea, changes in taste perception, gas, abdominal pain, headache, skin rash, and respiratory illness.
Patients with hypersensitivity to Triblend VG 2 Tablet ER constituents or inactive ingredients should not take this medication. Its use is contraindicated in individuals with moderate to severe renal impairment, inflammatory bowel disease, colonic ulcers, and underlying metabolic acidosis, such as diabetic ketoacidosis.
Consuming alcohol concurrently with Triblend VG 2 Tablet ER is unsafe. This combination risks further reduction of blood glucose (hypoglycemia) and elevates the probability of lactic acidosis.
Triblend VG 2 Tablet ER can induce hypoglycemia, characterized by low blood sugar. Manifestations of low blood sugar may include nausea, headache, irritability, hunger, sweating, dizziness, tachycardia, and feelings of anxiety or tremor. The risk increases with skipped or delayed meals, alcohol consumption, excessive physical activity, or concomitant use of other antidiabetic medications. Consequently, consistent blood glucose monitoring is crucial. Individuals should always carry readily available glucose sources, such as glucose tablets, honey, or fruit juice.
Maintain this medication within its original, sealed packaging. Store as directed on the packaging or label. Discard any remaining medication. Ensure it remains inaccessible to children, pets, and others.
Triblend VG 2 Tablet ER
117
MRP 143
18% off